2011
DOI: 10.1016/j.neuropharm.2011.05.017
|View full text |Cite
|
Sign up to set email alerts
|

Sex difference in sensitivity to allopregnanolone neuroprotection in mice correlates with effect on spontaneous inhibitory post synaptic currents

Abstract: Allopregnanolone (ALLO) is a neurosteroid that has many functions in the brain, most notably neuroprotection and modulation of gamma-amino butyric acid (GABA) neurotransmission. Using a mouse model of cardiac arrest and cardiopulmonary resuscitation, we have previously demonstrated that ALLO protects cerebellar Purkinje cells (PCs) from ischemia in a GABAA receptor-dependent manner. In this study we examined the effect of sex on ALLO neuroprotection, observing that low dose ALLO (2 mg/kg) provided greater neur… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
23
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 28 publications
(23 citation statements)
references
References 31 publications
0
23
0
Order By: Relevance
“…Such modifications within the brain have implications on seizure susceptibility within the developing hippocampus and changing neuronal network environment. In addition, allopregnanolone and other neurosteroids could have differential neuroprotective effects in male and females experiencing potential excitotoxic or ischemic events that could damage neurons (Kelley et al, 2011). …”
Section: Sex-specific Differencesmentioning
confidence: 99%
“…Such modifications within the brain have implications on seizure susceptibility within the developing hippocampus and changing neuronal network environment. In addition, allopregnanolone and other neurosteroids could have differential neuroprotective effects in male and females experiencing potential excitotoxic or ischemic events that could damage neurons (Kelley et al, 2011). …”
Section: Sex-specific Differencesmentioning
confidence: 99%
“…ALLO at nanomolar concentrations binds to GABA A receptors and potentiates the action of endogenous GABA, whereas at micromolar concentrations ALLO directly activates GABA A receptors (Figure 1), and thus may be able to reduce neuronal death following TBI or other insults (Paul and Purdy, 1992; Lambert et al, 2001; Magnaghi et al, 2006). For example, P4 and ALLO protect cerebellar Purkinje cells in vitro and in vivo from ischemia (Ardeshiri et al, 2006; Kelley et al, 2008, 2011). Furthermore, P4 effects were mediated by ALLO acting through GABA A receptors: treatment with finasteride, a 5α-reductase inhibitor that prevents metabolism of P4 to ALLO, abolished the protective effects of P4 while administration of a GABA A receptor antagonist abolished neuroprotective effects of both P4 and ALLO (Ardeshiri et al, 2006).…”
Section: Effects Through γ-Amino Butyric Acid Type a (Gabaa) Receptorsmentioning
confidence: 99%
“…They receive and integrate excitatory inputs from sensory, vestibular and motor areas to allow for temporally and spatially precise movement (Thach, 1998; Bastian, 2006). There is evidence of Purkinje cell loss in post-mortem examinations of cardiac arrest victims and in rodent models of global cerebral ischemia however, the mechanism of injury to these cells remains understudied (Horn & Schlote, 1992; Welsh et al ., 2002; Lim et al ., 2004; Kelley et al ., 2011). …”
Section: Introductionmentioning
confidence: 99%